MTOR and obesity due to melanocortin 4 receptor deficiency: Obesity (aOR: 0.87, 0.83, NA, respectively), group B blood (aOR: 0.93, 1.00, 0.81, respectively), hypertension (aOR: 0.75, 0.70, 0.75, respectively), diabetes (aOR, 0.75, 0.72, 0.90, respectively)-induced ESRD, diabetes history (aOR: 0.85, 0.80, 0.81, respectively), deceased donor (aOR: 0.77, 0.76, 0.89, respectively), and mTOR inhibitor (aOR: 0.74, 0.87, 0.77, respectively) could decrease the risk of PTSC incidence.